🇺🇸 FDA
Patent

US 9321820

Compositions and methods for treating bladder cancer

granted A61KA61K38/00A61K38/16

Quick answer

US patent 9321820 (Compositions and methods for treating bladder cancer) held by The Regents of the University of Colorado expires Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado
Grant date
Tue Apr 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/00, A61K38/16, A61K38/164, A61K38/1808